Free Trial

BlackRock Capital Allocation Term Trust (NYSE:BCAT) Sets New 12-Month Low - Here's Why

BlackRock Capital Allocation Term Trust logo with Manufacturing background
Remove Ads

BlackRock Capital Allocation Term Trust (NYSE:BCAT - Get Free Report)'s stock price reached a new 52-week low on Wednesday . The stock traded as low as $14.46 and last traded at $14.51, with a volume of 310923 shares. The stock had previously closed at $14.58.

BlackRock Capital Allocation Term Trust Stock Performance

The business has a 50 day moving average price of $15.26 and a 200-day moving average price of $15.77.

BlackRock Capital Allocation Term Trust Increases Dividend

The company also recently declared a monthly dividend, which will be paid on Monday, March 31st. Shareholders of record on Friday, March 14th will be paid a $0.2872 dividend. The ex-dividend date of this dividend is Friday, March 14th. This represents a $3.45 dividend on an annualized basis and a yield of 24.04%. This is a boost from BlackRock Capital Allocation Term Trust's previous monthly dividend of $0.10.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of BCAT. Ameriprise Financial Inc. lifted its stake in BlackRock Capital Allocation Term Trust by 1.9% in the 4th quarter. Ameriprise Financial Inc. now owns 44,528 shares of the company's stock valued at $675,000 after purchasing an additional 844 shares during the last quarter. Janney Montgomery Scott LLC lifted its position in shares of BlackRock Capital Allocation Term Trust by 13.2% in the fourth quarter. Janney Montgomery Scott LLC now owns 17,150 shares of the company's stock valued at $260,000 after buying an additional 2,000 shares during the last quarter. Comerica Bank boosted its stake in shares of BlackRock Capital Allocation Term Trust by 27.1% during the 4th quarter. Comerica Bank now owns 10,126 shares of the company's stock worth $153,000 after acquiring an additional 2,157 shares during the period. CIBC Private Wealth Group LLC acquired a new position in shares of BlackRock Capital Allocation Term Trust during the 4th quarter worth approximately $36,000. Finally, Anfield Capital Management LLC bought a new stake in BlackRock Capital Allocation Term Trust in the 4th quarter valued at $56,000. 36.12% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

BlackRock Capital Allocation Term Trust Company Profile

(Get Free Report)

-

Further Reading

Should You Invest $1,000 in BlackRock Capital Allocation Term Trust Right Now?

Before you consider BlackRock Capital Allocation Term Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BlackRock Capital Allocation Term Trust wasn't on the list.

While BlackRock Capital Allocation Term Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Free Today: Your Guide to Smarter Options Trades Cover

Learn how options trading can help you navigate market volatility, manage risk, and maximize returns with MarketBeat's "Unlock the Potential in Options Trading." Click the link below to have this special report delivered to your inbox.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

5 International Stocks to Escape U.S. Market Volatility

5 International Stocks to Escape U.S. Market Volatility

MarketBeat’s Chris Markoch shares 5 international stock picks that could offer protection—and potential opportunity—amid the current market uncertainty.

Related Videos

3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
3 AI Stocks to Watch After NVIDIA’s Dip

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads